Cerebral glucose metabolism in five patients with Lennox-Gastaut syndrome

Pediatr Neurol. 1987 Jan-Feb;3(1):12-8. doi: 10.1016/0887-8994(87)90047-6.

Abstract

Regional cerebral glucose metabolic rates were estimated by positron emission tomography, in parallel with electroencephalography and cranial computed tomography in 5 patients with Lennox-Gastaut syndrome. The 5 patients, 3 boys and 2 girls, ranged in age from 10-15 years. Computed tomography revealed no gross abnormalities. Each patient received 2-5 mCi of 2-(18F)-fluoro-2-deoxy-D-glucose (18F-FDG) intravenously. Averaged cerebral glucose metabolic rates were reduced in each cerebral region as compared with controls. Unilateral hypometabolism was present in 4 patients: one in the inferior frontal gyrus as well as the posterior portion of the superior temporal gyrus; one in the inferior frontal gyrus; one in the posterior portion of the superior temporal gyrus; and one demonstrated diffuse hemispheric hypometabolism including the inferior frontal and posterior portion of the superior temporal gyrus. The side of hypometabolism was the same as the epileptogenic focus on the electroencephalogram. No focal changes were demonstrated on the electroencephalogram of a patient whose positron emission tomography revealed hemispheric hypometabolism. Hypometabolism of the inferior frontal and posterior portion of the superior temporal gyrus may relate to the possible pathogenesis of Lennox-Gastaut syndrome. Positron emission tomography has the potential to reveal a latent focal or lateralized abnormality in some patients with non-localized electroencephalographic changes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Glucose / metabolism*
  • Brain / diagnostic imaging
  • Child, Preschool
  • Deoxyglucose / analogs & derivatives
  • Deoxyglucose / metabolism
  • Epilepsy, Absence / diagnostic imaging*
  • Epilepsy, Tonic-Clonic / diagnostic imaging*
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Male
  • Status Epilepticus / diagnostic imaging*
  • Syndrome
  • Tomography, Emission-Computed*

Substances

  • Blood Glucose
  • Fluorodeoxyglucose F18
  • Deoxyglucose